Ph.D., Professor Department of Biomedical Data Science, Stanford University
Dr. Lu is the Co-Director of the Stanford Center for Innovative Study Design (CISD) and the Biostatistics Core of the Stanford Cancer Institute. CISD develops optimal clinical trial/study designs that gather useful data, perform confirmatory testing, manage risk and are economically efficient and feasible through methodological research on innovative study designs, collaboration with clinical investigators and pharmaceutical industry to promote and implement novel trial designs, training students and professionals and establishment of global partnership with industry, academia and regulatory agencies. Dr. Lu’s research focuses in development of clinical trial design and statistical tools for precision medicine, biomarker validation, and medical decision making. Dr. Lu is an elected fellow of the American Statistical Association and Biostatistics Associate Editor of the JCO Precision Oncology.
Clinical & Research Tools Showcase: Stanford University
Stanford University is one of the world’s leading teaching and research institutions.
Trial Design and Analysis for Precision Medicine
Examples of novel trial designs for precision medicine are introduced: (1) a phase 1b design to determine biological effective dose for oncology trials; (2) adaptive enrichment designs for confirmatory trials; (3) simultaneous inference for subgroup and whole population.